Press "Enter" to skip to content

New patent for Celgene Corp drug OTEZLA

0
Copyright © DrugPatentWatch. Originally published at New patent for Celgene Corp drug OTEZLA

Annual Drug Patent Expirations for OTEZLA
Annual Drug Patent Expirations for OTEZLA

Otezla is a drug marketed by Celgene Corp and is included in one NDA. It is available from one supplier. There are ten patents protecting this drug and one Paragraph IV challenge.

OTEZLA drug price trends.

Drug patent litigation for OTEZLA.

This drug has eigthy-five patent family members in twenty-two countries.

The generic ingredient in OTEZLA is apremilast. One supplier is listed for this compound. Additional details are available on the apremilast profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Copyright © DrugPatentWatch. Originally published at New patent for Celgene Corp drug OTEZLA
Do NOT follow this link or you will be banned from the site!